Download our WMIC 2022 Poster
To request a copy of our poster, please complete the form and you will gain access to download.
%20-%20Edited.png)
Imagion Biosystems presented our most recent data related to our prostate cancer imaging agent at the 2022 World Molecular Imaging Congress held in Miami, FL Sep 28 – Oct 1.
The work was presented by Dr. Marie Zhang, VP of Research and Pre-Clinical Development at Imagion Biosystems:
The preclinical results presented provide strong evidence that our magnetic nanoparticle technology can be used to target prostate cancer tumors expressing the Prostate Specific Membrane Antigen (PSMA) with high specificity.
A molecular imaging agent based on magnetic imaging rather than the use of radioactivity will address the large unmet need of making non-invasive detection of prostate cancer more accessible and affordable and could reduce the need for prostate biopsies for many men, saving costs and improving patient care.
A copy of the poster is now made available. You can request a copy here.